PRRT2 and parasitic infectious disease: Mammalian PKCs have also been implicated in the regulation of malaria parasite egress from RBCs and treatment of P. berghei-infected mice with the PKC inhibitor sotrastaurin [71], [72] significantly decreased parasitemia and increased survival of infected hosts [73].